Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR
The structure was published by Schmitz, K.R., Bagchi, A., Roovers, R.C., van Bergen En Henegouwen, P.M., and Ferguson, K.M., in 2013 in a paper entitled "Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 3.054 Å and deposited in 2013.
The experimental data on which the structure is based was also deposited.
This entry contains 12 copies of 4 unique biopolymers (complete list).
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule most likely forms heterotetramers.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 1 unique UniProt protein: